Analysis of complement deposition and viral RNA in placentas of COVID-19 patients.

TitleAnalysis of complement deposition and viral RNA in placentas of COVID-19 patients.
Publication TypeJournal Article
Year of Publication2020
AuthorsJ Mulvey J, Magro CM, Ma LX, Nuovo GJ, Baergen RN
JournalAnn Diagn Pathol
Volume46
Pagination151530
Date Published2020 Jun
ISSN1532-8198
KeywordsBetacoronavirus, Coronavirus Infections, COVID-19, Female, Humans, Pandemics, Placenta, Pneumonia, Viral, Pregnancy, RNA, Viral, SARS-CoV-2, Thrombosis
Abstract

COVID-19, the disease caused by the novel Coronavirus, SARS-CoV-2, is increasingly being recognized as a systemic thrombotic and microvascular injury syndrome that may have its roots in complement activation. We had the opportunity to study the placental pathology of five full-term births to COVID-19 patients. All five exhibited histology indicative of fetal vascular malperfusion characterized by focal avascular villi and thrombi in larger fetal vessels. Vascular complement deposition in the placentas was not abnormal, and staining for viral RNA and viral spike protein was negative. While all cases resulted in healthy, term deliveries, these findings indicate the systemic nature of COVID-19 infection. The finding of vascular thrombosis without complement deposition may reflect the systemic nature of COVID-19's procoagulant effects unrelated to systemic complement activation.

DOI10.1016/j.anndiagpath.2020.151530
Alternate JournalAnn Diagn Pathol
PubMed ID32387855
PubMed Central IDPMC7182529
Grant ListP30 CA008748 / CA / NCI NIH HHS / United States
Related Faculty: 
Cynthia M. Magro, M.D.

Category:

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700